Smith Group Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Smith Group Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$840K	Buy	+13,850	New	+$807K	0.04%	99
2020 Q4	–	Sell	-323,739	Closed	-$19.5M	–	313
2020 Q3	$19.5M	Sell	323,739 -240,591	-43%	-$14.5M	1.02%	33
2020 Q2	$33.2M	Sell	564,330 -236,650	-30%	-$14.2M	1.83%	14
2020 Q1	$44.7M	Sell	800,980 -79,162	-9%	-$4.84M	2.44%	8
2019 Q4	$56.5M	Sell	880,142 -298,401	-25%	-$17.1M	2.37%	8
2019 Q3	$59.8M	Sell	1,178,543 -18,601	-2%	-$874K	2.1%	9
2019 Q2	$54.3M	Sell	1,197,144 -48,542	-4%	-$2.26M	1.82%	13
2019 Q1	$59.4M	Sell	1,245,686 -5,251	-0.4%	-$262K	1.93%	14
2018 Q4	$65M	Buy	1,250,937 +572,380	+84%	+$30.8M	2.29%	9
2018 Q3	$42.1M	Buy	+678,557	New	+$40.3M	1.2%	28
2016 Q3	–	Sell	-990,710	Closed	-$72.9M	–	455
2016 Q2	$72.9M	Buy	990,710 +807,050	+439%	+$57M	2.18%	9
2016 Q1	$11.7M	Buy	183,660 +18,080	+11%	+$1.14M	0.35%	82
2015 Q4	$11.4M	Buy	+165,580	New	+$10.9M	0.34%	81

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Smith Group Asset Management's BMY Position: Q1 2026 in Review

Smith Group Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 13,850 shares worth $840K. The stake represents 0.04% of the portfolio and ranks #99 among its holdings. This is a return to the name: Smith Group Asset Management previously reported a position in BMY as recently as Q3 2020.

Smith Group Asset Management first reported a position in BMY in Q4 2015 and has held it in 13 quarters since. The position peaked at $72.9M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Smith Group Asset Management held 13,850 shares of Bristol-Myers Squibb worth $840K as of Q1 2026.
Bristol-Myers Squibb was a new Smith Group Asset Management position in Q1 2026.
Bristol-Myers Squibb made up 0.04% of Smith Group Asset Management's portfolio in Q1 2026, its #99 holding.
Smith Group Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 13 quarters since.
Smith Group Asset Management's Bristol-Myers Squibb position peaked at $72.9M in Q2 2016.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.